INTRODUCTION
Sepsis is a deadly condition characterized by a whole-body inflammatory state (called a systemic inflammatory response syndrome or SIRS) and the presence of a known or suspected infection. [1, 2] The human body may develop this inflammatory response by the immune system to microbes in the blood, urine, lungs, skin, or other tissues. Sepsis is a leading cause of death in noncoronary intensive care units (ICUs) and the 10th leading cause of death in the United States. The incidence of severe sepsis in the United States is between 650 000 and 750 000 cases. [3, 4] Biomarkers may be helpful in stratification of risk and prediction of mortality in septic patients. The study aimed to investigate the diagnostic role of soluble triggering receptor expressed on myeloid cell-1 (sTREM-1), PCT, CRP and other inflammatory markers in patients with sepsis.
METHODS

Patients
This prospective, observational study was carried out in our multidisciplinary ICU between May 2009 to July 2010. The study protocol was approved by the Ethics Committee of the Second Hospital of Tianjin Medical University. Informed consent was obtained from all patients or their relatives if they were unconscious. A total of 81 consecutive patients who had been diagnosed with severe sepsis or septic shock (according to the surviving sepsis guidelines 2004) were enrolled in this study. Newly admitted patients (<24 hours), cancer patients, and those with severe trauma or major operation were excluded from the study.
The 81 patients were divided into a sepsis group (n=32), a systemic inflammation response syndrome group (SIRS group, n=24) and a control group (n=25) according to the diagnostic criteria of 2001 American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) Consensus Conference [5] : (1) sepsis as the clinical syndrome defined by the presence of infection and a systemic inflammatory response; (2) SIRS considered to be present when patients have more than one of the following clinical findings: body temperature >38 °C or <36 °C; heart rate>90 min -1 ; hyperventilation evidenced by a respiratory rate of >20 min -1 or a PaCO 2 of <32 mmHg; and a white blood cell count of >12 000 cells L -1 or <4000 L -1 ; (3) patients in the control group who didn't meet the SIRS criteria, but had focal infection, surgery or trauma.
The sepsis group was subdivided into a survival group and a death group, according to 28-day prognosis.
Methods
Within 24 hours after hospitalization, 2 mL blood was collected and put into sterile tubes. After centrifugation, serum was kept at -80 ˚C until assay.
Demographic data were recorded including medical history, diagnosis, pulse rate, blood pressure, respiratory rate, arterial blood gas, results of routine blood test, electrolytes, white blood cell count (WBC), neutrophil count (N), procalcitonin (PCT) and C-reactive protein (CRP). The severity of condition was measured according to APACHE-II scoring. In a 28-day follow-up, we recorded the number of patients who died of septic complications.
sTREM-1 concentration was measured by ELISA with a kit produced by the R&D Company in the United States. PCT and CRP were determined using a double antibody sandwich immunofluorescence semi-quantitative method and immunoturbidimetry respectively. PCT was divided into 4 levels: normal <0.5 μg/L, high ≥0.5 μg/L, higher ≥2.0 μg/L, and highest ≥10.0 μg/L.
Statistical analysis
Measurement data were expressed as mean ± standard deviation. They were compared by one-way analysis of variance (ANOVA) or the Kruskal-Wallis test. The data between the two groups were compared by Student's t test or the Mann-Whitney U test. Data were compared by the chi-square test. Spearman's rank-order correlation coefficient was used for correlation analysis. Then the receiver characteristic curve (ROC) of enrolled patients was drawn to determine the early diagnostic value of infl ammatory indicators in patients with sepsis. SPSS 16.0 statistical analysis software was used for data processing. P<0.05 was considered statistically signifi cant.
RESULTS
General information
In the sepsis group, 19 patients were male and 13 female, with an average age of 23-82 (64.8 ± 14.3) years. Twenty-one patients survived and 11 (34.4%) died. In the SIRS group, 14 patients were male and 10 female, and their average age was17-80 (62.5±16.0) years. In the control group, 14 patients were male and 11 female, with an average age of 20-77 (61.6±13.9) years. There was no significant difference in sex and age among the three groups (sepsis group, SIRS group and control group) (P≥0.05).
Plasma level of sTREM-1
Compared to the SIRS group, sTREM-1 significantly increased in the sepsis group (P<0.01). Compared to the control group, sTREM-1 significantly increased in the SIRS group (P<0.01). When serum PCT concentration ≥2 μg/L was set as positive, there was a signifi cant difference in positive rate (χ 2 1 =25.441, P 1 =0.000; χ 2 2 = 40.078, P 2 =0.000) among the three groups (sepsis group, SIRS group and control group), while there was no significant difference in positive rate (χ 2 =2.586, P=0.108) between the SIRS group and control group. When serum PCT concentration was set ≥10 μg/L as positive, there was a significant difference in positive rate (χ 2 =0.784, P=0.465) between the survival group and death group, whereas there was no significant difference in CRP, WBC, N and T (P≥0.05) among the three groups (sepsis group, SIRS group and control group) ( Tables 1, 2) . Correlation between plasma sTREM-1 levels and APACHE II score in sepsis patients Spearman's rank-order correlation coefficient analysis showed that the plasma sTREM-1 level was positively correlated with APACHE II score (r=0.426, P= 0.032) (Figure 1 ).
Diagnostic value of plasma level of sTREM-1 in patients with sepsis
The area under the ROC curve of sTREM-1 was 0.935; sTREM-1 showed a sensitivity of 93.8% and a specificity of 84.7% in the diagnosis of sepsis, and we considered sTREM-1>135 pg/mL as the best threshold. The area under the ROC curve of PCT was 0.891; PCT had a sensitivity of 84.4% and a specifi city of 87.8% in the diagnosis of sepsis, thus we considered PCT ≥2.0 μg/L as the best threshold. The area under the ROC curve of CRP was 0.602, indicating that CRP was unable to diagnose sepsis ( Figure 2 ).
DISCUSSION
Sepsis is caused by an infection as a systemic infl ammatory response. It may be difficult to distinguish from noninfectious systemic inflammatory response syndrome (SIRS). Hence its treatment and prognosis are different. Currently there are no diagnostic indicators for sepsis with a high specifi city and a sensitivity.
Traditional infl ammatory indicators include WBC, N, T, etc. In the present study, WBC and C played a role in the diagnosis of sepsis. WBC, N, T distinguished SIRS from non-SIRS, but there was no significant difference between the survival group and death group. This indicated that traditional inflammatory indicators are unable to refl ect the severity of sepsis.
CRP, an acute-phase protein, is used as a nonspecific inflammatory indicator, but CPR is not specific for infectious diseases. [6] Our study revealed a signifi cant difference in CPR among the sepsis group, SIRS group and control group; however, there was no significant difference in CPR between the sepsis group and SIRS group or between the survival group and non-survival group. This indicated that CRP is unable to reflect the prognosis of sepsis. P C T a s t h e b e s t i n f l a m m a t i o n i n d i c a t o r [ 7 , 8 ] can accurately distinguish SIRS from sepsis if its concentration is higher in sepsis patients. It was reported that PCT had a sensitivity of 71% and a specificity of 71% in the diagnosis of sepsis, and the area under the ROC curve of PCT was 0.78; therefore PCT is not used as a diagnostic value in critical patients. [9] Clinically semi-quantitative assay has been widely used to measure PCT. In the present study we found that if PCT ≥2.0 μg/ L was set as the threshold, PCT could distinguish SIRS from sepsis with a sensitivity of 84.4% and a specifi city of 87.8%, but could not distinguish SIRS from non-SIRS because PCT increased signifi cantly after occurrence of systemic infection. If PCT ≥10.0 μg/L was taken as the best threshold, there was no signifi cant difference in PCT between the survival group and death group, indicating that PCT semi-quantitative assay could not predict the prognosis of sepsis.
Triggering receptor expressed on myeloid cells-1 (TREM-1) is a sort of cell surface molecule expressed on granulocytes, monocytes and a subset of macrophages, which was discovered in 2000. [10] It is a member of the superfamily of immunoglobulins. When the human body is infected, bacterial products such as lipopolysaccharide (LPS) activate the Toll-like receptor (Toll-like receptor, TLR) to increase the expression of TREM-1, and then TREM-1 as a key media-mediator in sepsis promotes the inflammatory response. [11] The sTREM-1 is a protease hydrolysis product of TREM-1. It is able to bind with unknown TREM-1 ligand in blood and inhibit ligand to bind with TREM-1 in cell membrane, fi nally preventing the infl ammatory signal transduction. This may be one of the regulating ways for TREM-1 activating infl ammatory signaling pathways.
Recent studies have shown that sTREM-1 is promising for the diagnosis of sepsis and the prediction of prognosis. [12] [13] [14] When sTREM-1 of plasma is >60 μg/L in ICU sepsis patients, it is more accurate than any other clinical or laboratory indicators in predicting infection and sepsis with a sensitivity of 96% and a specificity of 89%. [15] A study found that sTREM-1 concentration was significantly lower at admission in non-survivors than in survivors. [16] In our study, plasma sTREM-1 concentration in the early course was higher in the sepsis group than in the SIRS group and control group, and sTREM-1 concentration was higher in the survivors than in the non-survivors. The area under the ROC curve of sTREM-1 was 0.935; if sTREM-1> 135 pg/mL was set as the best threshold, there were a sensitivity of 93.8% and a specifi city of 84.7% in the diagnosis of sepsis. The area under the ROC curve of sTREM-1 was similar to that of PCT, thus both sTREM-1 and PCT are of high value in the early diagnosis of sepsis, but PCT is unable to reflect the prognosis of sepsis. SOFA score is an effective indicator to show the severity and prognosis of sepsis. [17] In the present study, the plasma sTREM-1 level was positively correlated with APACHE II score, indicating that plasma sTREM-1 can refl ect the severity of sepsis to some extent. Combined sTREM-1 and SOFA score might be more valuable to predict the prognosis of patients with sepsis.
Experiments showed that injecting sTREM-1 homologous synthetic peptide can reduce the infl ammatory response in septic mice and also improve the prognosis. [18] But research is still preliminary. Further study is needed to explore whether targeted therapy associated with sTREM-1 can be a new way to treat sepsis.
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